{"summary": "nontuberculous mycobacteria (NTM) lung diseases are increasingly recognized as chronic opportunistic infections. decision of NTM lung disease treatment must relies on a careful risk/benefit assessment, given the requirement of long-term administration of multidrug therapies. aspergillus spp. co-infection was the only independent determinant of treatment initiation. the most relevant variable associated with anti-NTM treatment initiation was aspergillus spp. co-infection."}